CAR-T therapy alters synthesis of platelet-activating factor in multiple myeloma patients
The chimera antigen receptor (CAR) T cell therapy is a novel and potential targeted therapy and has achieved satisfactory efficacy in patients with relapsed or refractory multiple myeloma (MM) in recent years....
Source: Journal of Hematology and Oncology - Category: Hematology Authors: Mengying Ke, Liqing Kang, Ling Wang, Shu Yang, Yajun Wang, Haiyan Liu, Chunyan Gu, Hongming Huang and Ye Yang Tags: Letter to the Editor Source Type: research